Alzheimer's and Parkinson's charities identify new ways to reuse current drugs
This method of drug development could also reduce the time patients are left waiting for new treatments by up to 10 years, they added.
It comes after the NHS spending watchdog rejected the use of new Alzheimer's drugs lecanemab and donanemab for widespread use in the health service.
The drugs were approved for use in the UK last year by the UK's medicines regulator but the NHS spending watchdog, the National Institute for Health and Care Excellence (Nice), said they could not be used in the NHS because the benefits are 'too small' to justify the cost.
Now charities Cure Parkinson's and Alzheimer's Research UK have joined forces to find current drugs that may tackle some of the common biology behind both diseases.
https://x.com/AlzResearchUK/status/1929856926885539966/photo/2
After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson's over a decade ago, experts from both fields will select the most promising drugs for both Parkinson's and dementia, so they can be moved quickly into clinical trials.
Weight loss jabs are already being investigated for their effectiveness in treating symptoms of both diseases and experts hope to uncover more drugs that can have multiple uses.
Semaglutide, the active ingredient for weight loss and diabetes drugs Wegovy and Ozempic, is being examined in clinical trials to see whether it can help patients with Alzheimer's disease or Parkinson's.
Trial results for the Alzheimer's trial are expected to be published later this year.
Dr Sheona Scales, director of research at Alzheimer's Research UK, told the PA news agency that the iLCT project had already been 'hugely successful' with people who have Parkinson's, adding: 'Around 30% of disease modifying therapies that are in clinical trials for Parkinson's disease came through this process.
'What we wanted to do is to build on their knowledge and experience and expertise in order to be able to bring a process similar to that to Alzheimer's disease.'
Dr Scales said that there are some 'common grounds' between Parkinson's and Alzheimer's – both are neurodegenerative diseases and have some 'common biological processes' – such as inflammation, mitochondrial dysfunction and 'protein misfolding' – which could be targets for repurposed drugs.
'Getting multiple drugs that are targeting the disease is really important to us,' she said.
'Testing different types of drugs and getting as many shots on target is important.'
She said: 'Repurposed drugs have already been demonstrated to be safe for use in humans development of new drugs for different diseases is a long process.
'What essentially bringing repurposed drugs does, is help to accelerate the drug development pipeline – it could save between five and 10 years within that process, compared to taking a new drug through clinical trials for the very first time.'
Helen Matthews, chief executive of Cure Parkinson's, said the iLCT was originally set up to identify drugs that can potentially 'slow down, stop or reverse Parkinson's'.
She added: 'It was through this programme that we realised that there were so many drugs that were also being looked at in the dementia field and there were commonalities there in terms of the drugs looking to reduce inflammation, or whatever it might be, there were specific pathways that those drugs were working on that could be beneficial for both disease areas.
'So given that we were already doing the (work) every year, it made sense to join forces in this way, just to add efficiencies.
'Because if you're looking at the same drugs, we'll only do that digging once, you know, only do that compilation of the dossiers once, so that you can actually take the learning for both diseases and then actually look and see which might be beneficial.'
She said that the 'sharing of knowledge and digging' could also be shared with other disease areas, such as MS.
And on lecanemab and donanemab, Dr Scales added: '(These) were the first disease-targeting therapies that have been licensed in the UK, but obviously are not available on the NHS at the moment.
'They showed for the very first time that we were able to alter the course of the disease.
'And what we're looking forward to now is what the next generation of treatments can bring us and how we can target different parts of the disease.'
Dr Lucy Devendra, head of research at Alzheimer's Society, said: 'Repurposing medicines which are already known to be safe can help us find new treatments for the diseases that cause dementia much quicker.
'Although it is still early days, it's encouraging to see a renewed focus on this type of research and development.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
North Wales Live
a minute ago
- North Wales Live
Woman suffers 'life changing accident' while working as camp leader in USA
A woman has suffered a "life changing accident" while working as a camp leader in the USA, her family have said. Charlotte Hollins Anderton, 23, from Abergele, fell 30ft and waited eight hours to be rescued with a broken back, two broken feet and internal bleeding. She needed multiple operations and intensive care treatment, said her heartbroken family, who are well known in the town. Now a fundraising campaign has now been launched to help bring Charlotte home. A statement on the gofundme website said: "Our beautiful Charlotte was tragically involved in a life changing accident whilst working as a camp leader this summer. She has suffered a life threatening fall on the 4th July and has been hospitalised since. "Her fall resulted in spinal and foot fractures requiring multiple surgeries, internal bleeding and admission to the intensive care unit. She's also dealing with intense emotional trauma from the fall, and it breaks our hearts that we can't be there to help. "But on top of all of the unimaginable pain and suffering, while we have been deciding what to do as a family, we were just hit with another worry that her insurance company will not be covering the cost of repatriation from America to back home. "She urgently needs to come home for her to access specialist care via the NHS and continue her recovery with family by her side. "It is because of this that we are reaching out to her friends, and our community around us, to ask if anyone can spare anything to help us with the costs related to her care and journey home. Her repatriation currently costs £45,000. "We know this is a difficult time financially for so many, and if you are not able to donate, then PLEASE can we ask you to share this far and wide, on your social media and around your work." The famiily said they could never have imagined it would happen to them and they would be in this situation asking for support, when all they want "is to have her home." The statement added: "We will be keeping everyone updated every step of the way, and thank you all so much already for your kind words, promises of donations and support. It means more to us that you could imagine. "Thank you so much."
South Wales Argus
a minute ago
- South Wales Argus
BMA hits back after NHS says less than a third of resident doctors joined strike
The number that took part in the five-day walkout was down by 7.5% (1,243) on the previous round of industrial action in July last year, according to an early analysis of management information collected by NHS England. But the British Medical Association rejected this, saying complex work schedules and doctors taking leave make this information 'almost impossible to know'. NHS England said it maintained care for an estimated 10,000 more patients during the latest doctors' strike compared with last year's, and 93% of planned operations, tests and procedures went ahead. In previous walkouts, the majority of non-urgent care was postponed. Wes Streeting thanked 'those resident doctors who went to work for their commitment to their patients' (PA) Health Secretary Wes Streeting said: 'A majority of resident doctors didn't vote for strike action and data shows that less than a third of residents took part. 'I want to thank those resident doctors who went to work for their commitment to their patients and to our shared mission to rebuild the NHS.' He said it is time to 'move past the cycle of disruption'. He added: 'I want to end this unnecessary dispute and I will be urging the BMA to work with the Government in good faith in our shared endeavour to improve the working lives of resident doctors, rather than pursuing more reckless strike action.' The BMA said it recognised the efforts that senior doctors and healthcare workers made during the strike to provide care to patients, but it disputed the figure set out by the NHS. It said: 'NHS England's claim that the majority of England's 77,000 resident doctors chose to 'join the NHS-wide effort to keep the services open' requires a huge stretch of the imagination, given it is almost impossible to know the exact number of residents working on any given day because of complex work patterns, on-call schedules and the strike spread across a weekend. 'Added to that, in July many doctors are using up their remaining annual leave before their new posts start and would therefore not show up as striking. 'We look forward to seeing hard and fast data on NHS England's claim. 'The strike could have been averted, as could any future ones, if Mr Streeting had come, and will come, to the table with a credible offer that resident doctors in England can accept.' NHS chief executive Sir James Mackey noted care was still disrupted for thousands of people and said a repeat of strike action will be 'unacceptable'. 'I would urge the resident doctors committee to get back to the negotiating table and work with us and the Government on the meaningful improvements we can make to resident doctors' working lives.' NHS Providers, which represents hospital trusts, said the walkout took a toll and trusts are concerned about potential wider industrial action in the health service. Saffron Cordery, NHS Providers deputy chief executive, said: 'This dispute can't drag on. 'The union says resident doctors want this to be their last strike. With talks due to resume, let's hope so. Bringing disruptive strikes – where the only people being punished are patients – to an end must be a priority. 'We're concerned, as trusts worked hard to minimise disruption and to keep patients safe during the resident doctors' strike, by the threat of wider industrial action in the NHS.'
North Wales Chronicle
a minute ago
- North Wales Chronicle
BMA hits back after NHS says less than a third of resident doctors joined strike
The number that took part in the five-day walkout was down by 7.5% (1,243) on the previous round of industrial action in July last year, according to an early analysis of management information collected by NHS England. But the British Medical Association rejected this, saying complex work schedules and doctors taking leave make this information 'almost impossible to know'. NHS England said it maintained care for an estimated 10,000 more patients during the latest doctors' strike compared with last year's, and 93% of planned operations, tests and procedures went ahead. In previous walkouts, the majority of non-urgent care was postponed. Health Secretary Wes Streeting said: 'A majority of resident doctors didn't vote for strike action and data shows that less than a third of residents took part. 'I want to thank those resident doctors who went to work for their commitment to their patients and to our shared mission to rebuild the NHS.' He said it is time to 'move past the cycle of disruption'. He added: 'I want to end this unnecessary dispute and I will be urging the BMA to work with the Government in good faith in our shared endeavour to improve the working lives of resident doctors, rather than pursuing more reckless strike action.' The BMA said it recognised the efforts that senior doctors and healthcare workers made during the strike to provide care to patients, but it disputed the figure set out by the NHS. It said: 'NHS England's claim that the majority of England's 77,000 resident doctors chose to 'join the NHS-wide effort to keep the services open' requires a huge stretch of the imagination, given it is almost impossible to know the exact number of residents working on any given day because of complex work patterns, on-call schedules and the strike spread across a weekend. 'Added to that, in July many doctors are using up their remaining annual leave before their new posts start and would therefore not show up as striking. 'We look forward to seeing hard and fast data on NHS England's claim. 'The strike could have been averted, as could any future ones, if Mr Streeting had come, and will come, to the table with a credible offer that resident doctors in England can accept.' NHS chief executive Sir James Mackey noted care was still disrupted for thousands of people and said a repeat of strike action will be 'unacceptable'. 'I would urge the resident doctors committee to get back to the negotiating table and work with us and the Government on the meaningful improvements we can make to resident doctors' working lives.' NHS Providers, which represents hospital trusts, said the walkout took a toll and trusts are concerned about potential wider industrial action in the health service. Saffron Cordery, NHS Providers deputy chief executive, said: 'This dispute can't drag on. 'The union says resident doctors want this to be their last strike. With talks due to resume, let's hope so. Bringing disruptive strikes – where the only people being punished are patients – to an end must be a priority. 'We're concerned, as trusts worked hard to minimise disruption and to keep patients safe during the resident doctors' strike, by the threat of wider industrial action in the NHS.'
